We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Lilly Targets Actavis In Latest Cymbalta Patent Suit

Law360 (November 19, 2008, 12:00 AM EST) -- Eli Lilly and Co. added a fifth generic-drug maker to its bid to block competing versions of its antidepressant Cymbalta Tuesday, suing Actavis Elizabeth LLC over a patent for the blockbuster...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.